Corcept Therapeutics Inc (NAS:CORT)
$ 27.04 0.44 (1.65%) Market Cap: 2.82 Bil Enterprise Value: 2.36 Bil PE Ratio: 25.51 PB Ratio: 5.13 GF Score: 93/100

Corcept Therapeutics Inc Annual Shareholders Meeting Transcript

May 26, 2021 / 02:30PM GMT
Release Date Price: $21.45 (+1.42%)
Joseph K. Belanoff
Corcept Therapeutics Incorporated - Co-Founder, President, CEO & Director

Good morning. Welcome to our annual meeting of Stockholders. I am Joe Belanoff, Corcept's Chief Executive Officer, I will act as chairman of this meeting. Charlie Robb, our Chief Business Officer will act as Secretary.

The company hereby appoints Suzan Miller of CT Hagberg LLC to act as our inspector of elections. She will decide upon the qualifications of voters, accept their votes and count them. She's taken an oath to execute her duties with strict impartiality, which we will file with the records of the meeting.

If you encounter technical difficulties, call our support team at 1 (844) 986-0822 in the United States or 1 (303) 562-9302 internationally.

According to the inspector of election, we have received proxy votes for 102,368,830 of the 116,627,692 common shares outstanding on the record date, representing approximately 87.8% of our outstanding shares.

Having received a quorum of votes, the meeting is called to order. We will vote today by proxy. If you have

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot